Kenvue Inc. (NYSE:KVUE) Shares Sold by Clark Estates Inc. NY

Clark Estates Inc. NY decreased its position in Kenvue Inc. (NYSE:KVUE) by 5.0% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 950,000 shares of the company’s stock after selling 50,000 shares during the period. Kenvue makes up approximately 4.1% of Clark Estates Inc. NY’s holdings, making the stock its 4th biggest position. Clark Estates Inc. NY’s holdings in Kenvue were worth $21,974,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Huntington National Bank grew its position in shares of Kenvue by 26.5% during the 3rd quarter. Huntington National Bank now owns 4,161 shares of the company’s stock worth $96,000 after buying an additional 871 shares during the period. ING Groep NV grew its holdings in Kenvue by 23.6% in the third quarter. ING Groep NV now owns 3,576,616 shares of the company’s stock worth $82,727,000 after purchasing an additional 681,954 shares during the period. Lorne Steinberg Wealth Management Inc. increased its stake in Kenvue by 59.0% in the second quarter. Lorne Steinberg Wealth Management Inc. now owns 154,690 shares of the company’s stock valued at $2,812,000 after purchasing an additional 57,375 shares in the last quarter. Kennon Green & Company LLC raised its holdings in shares of Kenvue by 140.7% during the second quarter. Kennon Green & Company LLC now owns 159,106 shares of the company’s stock valued at $2,893,000 after purchasing an additional 93,008 shares during the period. Finally, Czech National Bank boosted its position in shares of Kenvue by 20.3% during the 2nd quarter. Czech National Bank now owns 364,886 shares of the company’s stock worth $6,634,000 after purchasing an additional 61,635 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have issued reports on KVUE shares. Bank of America increased their price target on Kenvue from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Tuesday, October 22nd. Royal Bank of Canada downgraded shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price target for the company. in a research report on Tuesday, September 24th. JPMorgan Chase & Co. boosted their price target on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. UBS Group raised their price objective on shares of Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. Finally, Jefferies Financial Group began coverage on shares of Kenvue in a report on Tuesday, September 24th. They set a “buy” rating and a $27.00 price objective for the company. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, Kenvue currently has an average rating of “Hold” and a consensus price target of $22.64.

Kenvue Trading Down 0.5 %

NYSE:KVUE opened at $24.12 on Wednesday. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $24.46. The firm has a 50-day moving average price of $22.87 and a two-hundred day moving average price of $20.92. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. The firm has a market cap of $46.24 billion, a price-to-earnings ratio of 43.85, a price-to-earnings-growth ratio of 2.20 and a beta of 1.36.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The company had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same quarter last year, the business posted $0.31 EPS. Kenvue’s quarterly revenue was down .4% compared to the same quarter last year. On average, equities analysts expect that Kenvue Inc. will post 1.07 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 27th. Stockholders of record on Wednesday, November 13th will be paid a dividend of $0.205 per share. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.82 annualized dividend and a dividend yield of 3.40%. Kenvue’s payout ratio is 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.